SCHEDULE: 11.2 Capital, Qian Zhuang Disclose Hinge Health Stake
Beneficial Ownership Disclosure
11.2 Capital entities and Qian Zhuang have disclosed significant beneficial ownership in Hinge Health, Inc.'s Class A Common Stock.
Summary
- Qian Zhuang, along with affiliated entities 11.2 Capital I, L.P., 11.2 Capital I Partners, LLC, 11.2 Capital HH, LLC, 11.2 Capital IVY, LLC, and 11.2 Capital Ivy Partners, LLC, have filed a Schedule 13G regarding their beneficial ownership in Hinge Health, Inc.
- As of June 30, 2025, Qian Zhuang beneficially owns 3,704,524 shares of Class A Common Stock, representing 12.1% of the class.
- 11.2 Capital I, L.P. and its general partner, 11.2 Capital I Partners, LLC, each beneficially own 2,703,954 shares, representing 9.1% of the class.
- 11.2 Capital HH, LLC beneficially owns 171,550 shares, representing 0.6% of the class.
- 11.2 Capital IVY, LLC beneficially owns 829,020 shares, representing 3.0% of the class.
- 11.2 Capital Ivy Partners, LLC beneficially owns 1,000,570 shares, representing 3.6% of the class.
- All beneficially owned shares are Class B common stock, convertible into Class A common stock on a one-for-one basis.
- Qian Zhuang is the sole managing member of 11.2 Capital I Partners, LLC and 11.2 Capital Ivy Partners, LLC, and holds sole voting and dispositive power over the shares held by 11.2 Capital I, 11.2 Capital HH, and 11.2 Capital IVY.
- The percentage ownership is calculated based on 26,909,512 shares of Class A common stock outstanding as of June 30, 2025, as reported in Hinge Health, Inc.'s Form 10-Q filed on August 11, 2025, adjusted for the full conversion of Class B common stock held by the Reporting Persons.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership, inherently neutral in sentiment regarding company performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of significant ownership by an investment entity and individual, common in the financial industry for transparency regarding large stakes in publicly traded companies. It does not provide specific insights into Hinge Health's operational performance or broader industry trends, but rather signals a notable investment position.
Related Party Transactions
- Qian Zhuang is the sole managing member of 11.2 Capital I Partners, LLC and 11.2 Capital Ivy Partners, LLC, which are general partners or managers of the other reporting entities (11.2 Capital I, L.P., 11.2 Capital HH, LLC, and 11.2 Capital IVY, LLC). This structure indicates a consolidated control over the reported shares by Qian Zhuang.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes by institutional and individual investors, which can influence market perception and potential future corporate actions.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires the filing of this statement, reflecting beneficial ownership. |
| 08/11/2025 | Date Hinge Health, Inc. filed its Quarterly Report on Form 10-Q, reporting outstanding Class A common stock. |
| 08/14/2025 | Date the Joint Filing Agreement was signed and the Schedule 13G was dated. |
Keywords
Hinge Health, 11.2 Capital, Qian Zhuang, Beneficial Ownership, Schedule 13G, Class A Common Stock, Investment, Shareholder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.